Karen Howarth

2.6k total citations
55 papers, 1000 citations indexed

About

Karen Howarth is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Karen Howarth has authored 55 papers receiving a total of 1000 indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Cancer Research, 26 papers in Pulmonary and Respiratory Medicine and 24 papers in Molecular Biology. Recurrent topics in Karen Howarth's work include Cancer Genomics and Diagnostics (47 papers), Lung Cancer Treatments and Mutations (25 papers) and Genetic factors in colorectal cancer (10 papers). Karen Howarth is often cited by papers focused on Cancer Genomics and Diagnostics (47 papers), Lung Cancer Treatments and Mutations (25 papers) and Genetic factors in colorectal cancer (10 papers). Karen Howarth collaborates with scholars based in United Kingdom, France and United States. Karen Howarth's co-authors include Paul A. Edwards, Nitzan Rosenfeld, Vincent Plagnol, Ludovic Lacroix, Benjamin Besse, Giovanni Marsico, David Planchard, Jean‐Charles Soria, Anas Gazzah and Nicholas C. Turner and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Karen Howarth

50 papers receiving 985 citations

Peers

Karen Howarth

PRM

ONCOL

PFM

Frédérique Berger France

Rosalía Caballero Spain

Daniel M. Klass United States

Chara Papadaki Greece

JS Reis‐Filho United Kingdom

Marie Acquafondata United States

Kim M. Smits Netherlands

Wakako Hamanaka Japan

Robert Lesurf United States

Alex H. Ramos United States

Frédérique Berger France

Karen Howarth

411 ×0.7

323 ×0.7

PRM

420 ×0.9

517 ×1.3

ONCOL

61 ×0.4

PFM

Citations per year, relative to Karen Howarth Karen Howarth (= 1×) peers Frédérique Berger

Countries citing papers authored by Karen Howarth

Since Specialization

Citations

This map shows the geographic impact of Karen Howarth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Howarth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Howarth more than expected).

Fields of papers citing papers by Karen Howarth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Howarth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Howarth. The network helps show where Karen Howarth may publish in the future.

Co-authorship network of co-authors of Karen Howarth

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Howarth. A scholar is included among the top collaborators of Karen Howarth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Howarth. Karen Howarth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mezquita, Laura, Marianne Oulhen, Marc Deloger, et al.. (2024). Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer. British Journal of Cancer. 130(4). 682–693. 1 indexed citations

Kfoury, Maria, Clément Bonnet, Nicolas Delanoy, et al.. (2024). Dynamic changes in TP53 mutated circulating tumor DNA predicts outcome of patients with high-grade ovarian carcinomas. International Journal of Gynecological Cancer. 34(11). 1836–1839.

Saal, Lao H., Niklas Loman, Yilun Chen, et al.. (2024). Monitoring ctDNA dynamics in early breast cancer using a novel ultra-sensitive tumor-informed structural variant approach combining whole-genome sequencing and multiplex dPCR.. Journal of Clinical Oncology. 42(16_suppl). 568–568. 1 indexed citations

Howarth, Karen, Christodoulos Pipinikas, Sophie Hackinger, et al.. (2024). Personalized cell-free tumor DNA analysis for patients with HNSCC: Liquid biopsy for minimal residual disease detection in head and neck squamous cell carcinoma (LIONESS).. Journal of Clinical Oncology. 42(16_suppl). 3010–3010.

Elliott, Mitchell J., Zachary Veitch, Philippe L. Bédard, et al.. (2023). Abstract P6-01-16: Circulating Tumour DNA (ctDNA) Detection and Dynamics in Patients with Early Breast Cancer (EBC): Results of the Neoadjuvant TRACER cohort. Cancer Research. 83(5_Supplement). P6–1. 2 indexed citations

Howarth, Karen, Sophie Hackinger, Christodoulos Pipinikas, et al.. (2022). Liquid BIOpsy for MiNimal RESidual DiSease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS) – A personalised analysis of circulating cell-free tumour DNA. Laryngo-Rhino-Otologie. 101(S 02). S205–S205. 1 indexed citations

Mezquita, Laura, Siddhartha Devarakonda, Mihaela Aldea, et al.. (2022). Exploring the Feasibility of Utilizing Limited Gene Panel Circulating Tumor DNA Clearance as a Biomarker in Patients With Locally Advanced Non-Small Cell Lung Cancer. Frontiers in Oncology. 12. 856132–856132. 2 indexed citations

Lipsyc-Sharf, Marla, Elza C. de Bruin, Robert McEwen, et al.. (2022). Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer. Journal of Clinical Oncology. 40(22). 2408–2419. 85 indexed citations

Howarth, Karen, Susanna L. Cooke, Suet‐Feung Chin, et al.. (2021). NRG1 fusions in breast cancer. Breast Cancer Research. 23(1). 3–3. 17 indexed citations

10.

Facchinetti, Francesco, Ludovic Lacroix, Laura Mezquita, et al.. (2020). Molecular mechanisms of resistance to BRAF and MEK inhibitors in BRAFV600E non–small cell lung cancer. European Journal of Cancer. 132. 211–223. 64 indexed citations

11.

Remón, Jordi, Aurélie Swalduz, David Planchard, et al.. (2020). Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assay. PLoS ONE. 15(6). e0234302–e0234302. 14 indexed citations

12.

Sale, Matthew J., Kathryn Balmanno, Eiko Ozono, et al.. (2019). MEK1/2 inhibitor withdrawal reverses acquired resistance driven by BRAFV600E amplification whereas KRASG13D amplification promotes EMT-chemoresistance. Nature Communications. 10(1). 2030–2030. 41 indexed citations

13.

Remón, Jordi, Caroline Caramella, Cécile Jovelet, et al.. (2017). Osimertinib benefit inEGFR-mutant NSCLC patients withT790M-mutation detected by circulating tumour DNA. Annals of Oncology. 28(4). 784–790. 133 indexed citations

14.

Remón, Jordi, Caroline Caramella, Ludovic Lacroix, et al.. (2017). P3.02b-102 Osimertinib Benefit in ctDNA T790M Positive, EGFR-Mutant NSCLC Patients. Journal of Thoracic Oncology. 12(1). S1254–S1255. 2 indexed citations

15.

Piccirillo, Sara, Inmaculada Spiteri, Andrea Sottoriva, et al.. (2014). Contributions to Drug Resistance in Glioblastoma Derived from Malignant Cells in the Sub-Ependymal Zone. Cancer Research. 75(1). 194–202. 43 indexed citations

16.

Gilley, Rebecca, Kathryn Balmanno, Matthew J. Sale, et al.. (2013). Adaptation to mTOR kinase inhibitors by amplification of eIF4E to maintain cap-dependent translation. Journal of Cell Science. 127(Pt 4). 788–800. 66 indexed citations

17.

Newman, Scott, Karen Howarth, Chris Greenman, et al.. (2013). The Relative Timing of Mutations in a Breast Cancer Genome. PLoS ONE. 8(6). e64991–e64991. 15 indexed citations

18.

Batty, Elizabeth M., Jessica C. Pole, Katherine A Blood, et al.. (2012). Structural analysis of the genome of breast cancer cell line ZR-75-30 identifies twelve expressed fusion genes. BMC Genomics. 13(1). 719–719. 35 indexed citations

19.

Pole, Jessica C., Frank McCaughan, Scott Newman, et al.. (2011). Single-molecule analysis of genome rearrangements in cancer. Nucleic Acids Research. 39(13). e85–e85. 2 indexed citations

20.

Howarth, Karen, Bee Ling Ng, Susanna L. Cooke, et al.. (2007). Array painting reveals a high frequency of balanced translocations in breast cancer cell lines that break in cancer-relevant genes. Oncogene. 27(23). 3345–3359. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact